US 10300150
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted A61KA61K38/162A61K45/06
Quick answer
US patent 10300150 (Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells) held by Aura Biosciences, Inc. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aura Biosciences, Inc.
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K38/162, A61K45/06, A61K47/6901, A61K47/6929